Key facts
- Notable investors include Guangdong Dongna Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Fiberlink Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Fiberlink Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fiberlink Biotechnology
Manufacturer of full-structure fibronectin technologies intended to advance its application across biomedical research and healthcare. The company offers full-structure extracellular matrix protein development capabilities, enabling biopharmaceutical developers, cell culture researchers, wound-care innovators, and cardiovascular research teams to achieve performance in adhesion studies, cultivation processes, and regenerative-health applications.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Fiberlink Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fiberlink Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fiberlink Biotechnology in its N-PORT filings yet. We sweep new filings monthly.